TITLE

NASH may be trash

AUTHOR(S)
Cassiman, David; Jaeken, Jaak
PUB. DATE
February 2008
SOURCE
Gut;Feb2008, Vol. 57 Issue 2, p141
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the authors' insights on non-alcoholic steatohepatitis (NASH) in relation to liver disease and cites its unapparent distinction to non-alcoholic fatty liver disease (NAFLD). They comment that the uncertainty of the sampling error for the distinction between NASH and NAFLD reflects an unproductive attitude towards fatty liver and its pathophysiology. They discuss several reasons of the uncertainty and cite questionable diagnosis of these diseases.
ACCESSION #
28843097

 

Related Articles

  • Current and Future Therapeutic Strategies in NAFLD. de Alwis, Nimantha Mark Wilfred; Day, Christopher Paul // Current Pharmaceutical Design;6/11/2010, Vol. 16 Issue 17, p1958 

    Non alcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and considered to be the commonest liver disorder in Western countries. It comprises a disease spectrum ranging from simple steatosis (fatty liver), through non-alcoholic steatohepatitis (NASH) to fat with fibrosis and...

  • Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis. Medina, Jesús; Fernández-Salazar, Luis I.; García-Buey, Luisa; Moreno-Otero, Ricardo // Diabetes Care;Aug2004, Vol. 27 Issue 8, p2057 

    Nonalcoholic steatohepatitis (NASH) represents an advanced stage of fatty liver disease developed in the absence of alcohol abuse. Its increasing prevalence in western countries, the diagnostic difficulties by noninvasive tests, and the possibility of progression to advanced fibrosis and even...

  • The Pervading Influence of Alcoholic Liver Disease in Hepatology. Williams, Roger // Alcohol & Alcoholism;Jul/Aug2008, Vol. 43 Issue 4, p393 

    Rising levels of alcohol consumption in the UK are leading to substantial increases in morbidity and mortality from liver disease. Drinking is starting at an earlier age with binging an increasing common pattern, and women are overtaking men in the consumption. Manifestations of liver damage...

  • MEDIEVAL THERAPY FOR A MODERN DISEASE? PRELIMINARY RESULTS OF A RANDOMISED CONTROLLED TRIAL.  // Gut;Apr2004 Supplement 3, Vol. 53, pA83 

    Non-alcoholic steatohepatitis (NASH) is an increasingly recognised clinical problem with few if any accepted treatments. Hepatic iron may be a cofactor for hepatic fibrosis in NASH. Aims of this study is to assess the effect of iron depletion by venesection treatment on liver function tests,...

  • Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients. Durango, Esteban; Dietrich, Christian; Seitz, Helmut Karl; Kunz, Cornelia Ursula; Pomier-Layrargues, Gilles T.; Duarte-Rojo, Andres; Beaton, Melanie; Elkhashab, Magdy; Myers, Robert P.; Mueller, Sebastian // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p43 

    Background: A novel Fibroscan XL probe has recently been introduced and validated for obese patients, and has a diagnostic accuracy comparable with that of the standard M probe. The aim of this study was to analyze and understand the differences between these two probes in nonobese patients, to...

  • Is transient elastography a useful tool for screening liver disease? Del Poggio, Paolo; Colombo, Silvia; Castellote, Jose // World Journal of Gastroenterology;3/28/2009, Vol. 15 Issue 12, p1409 

    Transient elastography (TE) is a new non invasive tool for measuring liver stiffness, which is correlated to the histologic stage of liver fibrosis. Several studies in chronic liver disease (CLD) have determined a good accuracy of TE in predicting significant fibrosis and an optimal accuracy in...

  • Nonalcoholic Fatty Liver Disease: Diagnosis and Management. WILKINS, THAD; TADKOD, ALTAF; HEPBURN, IRYNA; SCHADE, ROBERT R. // American Family Physician;7/1/2013, Vol. 88 Issue 1, p36 

    Nonalcoholic fatty liver disease is characterized by excessive fat accumulation in the liver (hepatic steatosis). Nonalcoholic steatohepatitis is characterized by steatosis, liver cell injury, and inflammation. The mechanism of nonalcoholic fatty liver disease is unknown but involves the...

  • Implication of tumor necrosis factor alpha receptor 1 and hexosaminidase: relationship to pathogenesis of liver diseases. Idriss, N.; Sayyed, Hayam; Zakhary, M.; Sayed, Sherif // Comparative Clinical Pathology;Jul2014, Vol. 23 Issue 4, p1095 

    Liver disease is the main cause of morbidity and mortality worldwide. The spectrum of the disease ranged from fatty liver to hepatic inflammation, necrosis, progressive fibrosis, and hepatocellular carcinoma. We evaluated the serum levels of soluble tumor necrosis factor alpha receptor 1, total...

  • Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? Shigefuku, Ryuta; Takahashi, Hideaki; Kobayashi, Minoru; Ikeda, Hiroki; Matsunaga, Kotaro; Okuse, Chiaki; Matsumoto, Nobuyuki; Maeyama, Shiro; Sase, Shigeru; Suzuki, Michihiro; Itoh, Fumio // Journal of Gastroenterology;Nov2012, Vol. 47 Issue 11, p1238 

    Introduction: Effective noninvasive tests that can distinguish early-stage nonalcoholic steatohepatitis (NASH) from simple steatosis (SS) have long been sought. Our aim was to determine the possibility of noninvasively distinguishing early-stage NASH from SS. Materials and methods: We used...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics